AbbVie, a US biopharmaceutical company, has reached an agreement with the Trump administration to improve healthcare accessibility and affordability for Americans. The company will invest $100 billion over the next ten years in US research and develo

2026-01-13

AbbVie, a US biopharmaceutical company, has reached an agreement with the Trump administration to improve healthcare accessibility and affordability for Americans. The company will invest $100 billion over the next ten years in US research and development and capital investment (including manufacturing).